➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Colorcon
Boehringer Ingelheim
Merck
Harvard Business School
Dow
McKesson

Last Updated: June 24, 2021

DrugPatentWatch Database Preview

Drugs in Development Information for Neuropeptide Y


Email this page to a colleague

« Back to Dashboard

What is the drug development status for Neuropeptide Y?

Neuropeptide Y is an investigational drug.

There have been 5 clinical trials for Neuropeptide Y. The most recent clinical trial was a Phase 2 trial, which was initiated on December 1st 2015.

The most common disease conditions in clinical trials are Disease, Stress Disorders, Traumatic, and Stress Disorders, Post-Traumatic. The leading clinical trial sponsors are James Murrough, Dennis Charney, and University of Texas Southwestern Medical Center.

There are two hundred and sixty-nine US patents protecting this investigational drug and three international patents.

Recent Clinical Trials for Neuropeptide Y
TitleSponsorPhase
Sympathetic Transduction in Obesity-associated Hypertension (OB-HTN)University of Texas Southwestern Medical CenterEarly Phase 1
Intranasal Neuropeptide Y in Clinical Trial in Level Two Trauma Patients for PTSD and Acute Stress DisorderU.S. Army Medical Research and Development CommandPhase 1/Phase 2
Intranasal Neuropeptide Y in Clinical Trial in Level Two Trauma Patients for PTSD and Acute Stress DisorderWestchester Medical CenterPhase 1/Phase 2

See all Neuropeptide Y clinical trials

Clinical Trial Summary for Neuropeptide Y

Top disease conditions for Neuropeptide Y
Top clinical trial sponsors for Neuropeptide Y

See all Neuropeptide Y clinical trials

US Patents for Neuropeptide Y

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Neuropeptide Y   Try Before You Buy Neuropeptide Y-derived peptides University of Copenhagen (Copenhagen K, DK) N.ae butted.stved Hospital (N.ae butted.stved, DK)   Try Before You Buy
Neuropeptide Y   Try Before You Buy Methods for the treatment of kidney fibrosis THE BRIGHAM AND WOMEN'S HOSPITAL, INC. (Boston, MA)   Try Before You Buy
Neuropeptide Y   Try Before You Buy Method using an Y1 receptor activator for treating an anticancer agent-induced nephrotoxic injury KYUNGPOOK NATIONAL UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION (KR)   Try Before You Buy
Neuropeptide Y   Try Before You Buy Diagnostic method for diagnosing depression and monitoring therapy effectiveness BRAINLABS B.V. (NL) RIJKSUNIVERSITEIT GRONINGEN (NL) ACADEMISCH ZIEKENHUIS GRONINGEN (NL)   Try Before You Buy
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Neuropeptide Y

Drugname Country Document Number Estimated Expiration Related US Patent
Neuropeptide Y Denmark DK2983690 2033-04-10   Try Before You Buy
Neuropeptide Y European Patent Office EP2983690 2033-04-10   Try Before You Buy
Neuropeptide Y Spain ES2729970 2033-04-10   Try Before You Buy
Neuropeptide Y Poland PL2983690 2033-04-10   Try Before You Buy
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
AstraZeneca
Harvard Business School
McKesson
Mallinckrodt
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.